Manufacturer
OPKO Pharmaceuticals
- Products listed
- 10
- Molecules
- 4
- Therapy areas
- 1
OPKO Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 10 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- OPKO Pharmaceuticals LLC, OPKO Pharmaceuticals, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply OPKO Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Oncology
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cyclophosphamide 25 mg capsuleOralGeneric name | Cyclophosphamide | US FDA | Available on request |
| Cyclophosphamide 50 mg capsuleOralGeneric name | Cyclophosphamide | US FDA | Available on request |
| Exemestane 25 mg tabletOralGeneric name | Exemestane | US FDA | Available on request |
| Temozolomide 100 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 140 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 180 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 20 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 250 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 5 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
Other products
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Rayaldee 30 mcg extended-release capsuleOral | Calcifediol | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from OPKO Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.